University of Melbourne Oct 24 2024 An international team of researchers has found that an antibiotic commonly prescribed for patients with liver disease, called rifaximin, has led to the global emergence of an almost untreatable form of the antimicrobial resistant superbug vancomycin-resistant enterococcus faecium (VRE), which frequently causes serious infections in hospitalized patients. The study has demonstrated that rifaximin usage is driving resistance to daptomycin, one of the last

Tag-uri: Medicamente